TN2015000263A1 - Acute kidney injury - Google Patents

Acute kidney injury

Info

Publication number
TN2015000263A1
TN2015000263A1 TNP2015000263A TN2015000263A TN2015000263A1 TN 2015000263 A1 TN2015000263 A1 TN 2015000263A1 TN P2015000263 A TNP2015000263 A TN P2015000263A TN 2015000263 A TN2015000263 A TN 2015000263A TN 2015000263 A1 TN2015000263 A1 TN 2015000263A1
Authority
TN
Tunisia
Prior art keywords
kidney injury
acute kidney
predicting
severity
relates
Prior art date
Application number
TNP2015000263A
Other languages
English (en)
Inventor
Frank Dieterle
Holger Hoefling
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TN2015000263A1 publication Critical patent/TN2015000263A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Primary Health Care (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Signal Processing (AREA)
  • Artificial Intelligence (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
TNP2015000263A 2012-12-20 2015-06-09 Acute kidney injury TN2015000263A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261740303P 2012-12-20 2012-12-20
PCT/EP2013/077253 WO2014096110A1 (fr) 2012-12-20 2013-12-18 Insuffisance rénale aiguë

Publications (1)

Publication Number Publication Date
TN2015000263A1 true TN2015000263A1 (fr) 2016-10-03

Family

ID=49885245

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2015000263A TN2015000263A1 (fr) 2012-12-20 2015-06-09 Acute kidney injury

Country Status (20)

Country Link
US (1) US20150309052A1 (fr)
EP (1) EP2936160A1 (fr)
JP (2) JP6416778B2 (fr)
KR (1) KR20150096728A (fr)
CN (1) CN104871004A (fr)
AR (1) AR094118A1 (fr)
AU (2) AU2013360685A1 (fr)
BR (1) BR112015014232A2 (fr)
CA (1) CA2895096A1 (fr)
CL (1) CL2015001768A1 (fr)
HK (1) HK1209838A1 (fr)
IL (1) IL239431A0 (fr)
MA (1) MA38171B1 (fr)
MX (1) MX2015008108A (fr)
PH (1) PH12015501399A1 (fr)
RU (1) RU2015129496A (fr)
SG (1) SG11201504329RA (fr)
TN (1) TN2015000263A1 (fr)
TW (1) TW201430347A (fr)
WO (1) WO2014096110A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019037043A1 (fr) * 2017-08-24 2019-02-28 菲鹏生物股份有限公司 Kit de détection d'une lésion rénale aiguë
CN108986915B (zh) * 2018-07-24 2021-07-06 戴松世 人工智能的急性肾损伤的早期预测方法和装置
WO2020064995A1 (fr) * 2018-09-28 2020-04-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Utilisation de biomarqueurs représentant des voies cardiaques, vasculaires et inflammatoires permettant la prédiction d'une lésion rénale aiguë chez des patients atteints de diabète de type 2
KR20200042725A (ko) 2018-10-16 2020-04-24 (주) 솔 렌즈 프리 cmos 광자 어레이 센서의 노이즈 특성 평가 방법
US20220301711A1 (en) * 2019-06-11 2022-09-22 The Regents Of The University Of California Systems and Methods for Machine Learning-based Identification of Acute Kidney Injury in Trauma Surgery and Burned Patients
CN110441457A (zh) * 2019-08-02 2019-11-12 深圳市绿航星际太空科技研究院 一种检测尿液中同型半胱氨酸的方法
CN112114125A (zh) * 2020-08-27 2020-12-22 中国医学科学院北京协和医院 一种评估肾脏储备功能的方法和系统及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1340086T3 (da) * 2000-10-17 2008-12-01 Besst Test Aps Assay til direkte detektion af en RS-virusrelateret biologisk celle i en legemsvæskepröve
ATE316653T1 (de) * 2000-10-17 2006-02-15 Besst Test Aps Test zum direkten nachweis eines inflammatorischen anzeiger in einer körperflüssigkeitsprobe
JP2004511808A (ja) * 2000-10-17 2004-04-15 ベッスト−テスト　アンパーツゼルスカブ 体液サンプル中の生物学的細胞の直接的検出のためのアッセイ
US20090238812A1 (en) * 2008-03-18 2009-09-24 Biotrin Intellectual Properties Limited Method for the early indentification and prediction of an abrupt reduction in kidney function in a patient undergoing cardiothoracic surgery
MX2011004767A (es) * 2008-11-10 2011-09-06 Astute Medical Inc Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
WO2010057184A2 (fr) * 2008-11-17 2010-05-20 The Brigham And Women's Hospital, Inc. Procédés pour la détection de lésion rénale aiguë chez des humains
AU2009318813B2 (en) * 2008-11-21 2016-11-24 Future Medical Diagnostics Co., Ltd Methods, devices and kits for detecting or monitoring acute kidney injury
CN101706497A (zh) * 2009-11-05 2010-05-12 武汉三鹰生物技术有限公司 人tff3的elisa检测试剂盒
US10324093B2 (en) * 2009-11-07 2019-06-18 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2569631A4 (fr) * 2010-05-10 2013-12-04 Austin Health Marqueurs de lésion rénale aiguë
EP2661620A4 (fr) * 2011-01-08 2014-07-16 Astute Medical Inc Procédé et compositions pour diagnostiquer et pronostiquer une lésion rénale et une insuffisance rénale

Also Published As

Publication number Publication date
PH12015501399A1 (en) 2015-09-07
EP2936160A1 (fr) 2015-10-28
MA38171A1 (fr) 2016-11-30
WO2014096110A1 (fr) 2014-06-26
RU2015129496A (ru) 2017-01-26
BR112015014232A2 (pt) 2017-07-11
IL239431A0 (en) 2015-07-30
MA38171B1 (fr) 2017-07-31
AR094118A1 (es) 2015-07-08
CA2895096A1 (fr) 2014-06-26
CN104871004A (zh) 2015-08-26
AU2017232081A1 (en) 2017-10-12
MX2015008108A (es) 2015-11-06
CL2015001768A1 (es) 2015-10-09
HK1209838A1 (en) 2016-04-08
KR20150096728A (ko) 2015-08-25
TW201430347A (zh) 2014-08-01
SG11201504329RA (en) 2015-07-30
AU2013360685A1 (en) 2015-07-02
JP2019053067A (ja) 2019-04-04
JP6416778B2 (ja) 2018-10-31
US20150309052A1 (en) 2015-10-29
JP2016503162A (ja) 2016-02-01

Similar Documents

Publication Publication Date Title
LTPA2020510I1 (lt) Pakeistieji 4-fenil-piridinai, skirti su NK-receptoriumi susijusių ligų gydymui
TN2015000263A1 (fr) Acute kidney injury
BR112014032116A2 (pt) método.
UA110813C2 (uk) Лікування ліподистрофії
UY34654A (es) Inhibidores de la beta-secretasa
BR112015000568A2 (pt) estimativa do parâmetro de anisotropia.
DK2721933T3 (da) Emulsion
BR112014027219A2 (pt) método
DE102012103585A8 (de) Druckmessaufnehmer
DK2914574T3 (da) Ny fremgangsmåde
BR112015002575A2 (pt) processamento submarino.
EP3205347A4 (fr) Inhibiteur de formation de piege extracelluaire de leucocytes
DE112013006162A5 (de) Schwingungsdämpfer
DE112013003695A5 (de) Elektrolyseur
CL2016000940A1 (es) Predicción de rasgos híbridos.
ES1095555Y (es) Criadero de caracoles.
FR3016072B1 (fr) Parabole acoustique
FR2973705B1 (fr) Inhibiteur de tnf-alpha.
ES1075828Y (es) Jamonero
BR112013026325A2 (pt) aparelho de cesto hidráulico
TH1401002454B (th) อุปกรณ์สำหรับการตัดด้วยคลื่นเหนือเสียง
TH1601002555A (th) เบนซาไมด์ซึ่งถูกแทนที่สำหรับการปฏิบัติต่อสัตว์ขาปล้อง
TH1301005041B (th) วิธีการสำหรับการประเมินความคงตัวทางเคมีของโพลีคลอโรพรีนลาเท็กซ์
UA24342S (uk) Акустична система
TH1401005984B (th) วิธีการสำหรับการแยกของโอเลฟินด้วยการแยกสลายแบบอ่อน